Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/INNOVACAP stock hub

NSE/INNOVACAP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/INNOVACAPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

50.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/INNOVACAP

In the news

Latest news · NSE/INNOVACAP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.8

P25 24.9P50 32.4P75 45.7

Trailing P/E35.6

P25 24.8P50 35.9P75 56.9

ROE13.7

P25 6.3P50 13.6P75 18.1

ROIC11.4

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/INNOVACAP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

INR

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,600
Enterprise value	INR 53.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE0DUT01020
Last refreshed	2026-05-10
Market cap	INR 50.1B
Price	INR 877
Price currency	INR
Rev Per Employee	10,233,987.5x
Sector	Healthcare
Sic	2834
Symbol	nse/INNOVACAP
Website	https://innovacaptab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.81%
EV Earnings	37.68x
EV/EBIT	25.88x
EV/EBITDA	21.21x
EV/FCF	107.97x
EV/Sales	3.24x
FCF yield	0.98%
Forward P/E	25.83x
P/B ratio	4.59x
P/E ratio	35.56x
P/S ratio	3.06x
PE Ratio3 Y	35.5x
PEG ratio	1.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.53%
EBITDA Margin	15.29%
FCF margin	3%
Gross margin	35.7%
Gross Profit	INR 5.8B
Gross Profit Growth	38.92%
Gross Profit Growth Q	41.4%
Gross Profit Growth3 Y	36.27%
Net Income	INR 1.4B
Net Income Growth	9.87%
Net Income Growth Q	28.78%
Net Income Growth Quarters	2%
Net Income Growth Years	6%
Net Income Growth3 Y	27.52%
Pretax Margin	11.5%
Profit Margin	8.61%
Profit Per Employee	INR 880,731
Profitable Years	9
ROA	7.5
Roa5y	9.02
ROCE	15.28
ROE	13.75
Roe5y	21.75
ROIC	11.42
Roic5y	15.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.46%
EPS Growth	9.89
EPS Growth Q	28.63
EPS Growth Quarters	2
EPS Growth Years	4
EPS Growth3 Y	20.27
OCF Growth	82.5%
OCF Growth3 Y	20.18%
Revenue Growth	31.66x
Revenue Growth Q	42.77x
Revenue Growth Quarters	8x
Revenue Growth Years	6x
Revenue Growth3 Y	20.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.96
Assets	INR 18.4B
Cash	INR 451.5M
Current Assets	INR 9.2B
Current Liabilities	INR 4.9B
Debt	INR 3.4B
Debt EBITDA	INR 1.37
Debt Equity	INR 0.32
Debt FCF	INR 6.99
Equity	INR 10.9B
Interest Coverage	12.14
Liabilities	INR 7.5B
Long Term Assets	INR 9.1B
Long Term Liabilities	INR 2.5B
Net Cash	INR -3B
Net Cash By Market Cap	INR -5.96
Net Debt EBITDA	INR 1.19
Net Debt Equity	INR 0.27
Net Debt FCF	INR 6.07
Tangible Book Value	INR 10.7B
Tangible Book Value Per Share	INR 187
WACC	3.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.87
Inventory Turnover	4.29
Net Working Capital	INR 5.1B
Quick ratio	0.98
Working Capital	INR 4.3B
Working Capital Turnover	INR 4.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 4
Dividend Years	1
Dividend Yield	0.46%
Ex Div Date	2026-01-30
Last Dividend	INR 2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.46%
200-day SMA	772.3
50-day SMA	714.3
50-day SMA vs 200-day SMA	50under200
All Time High	1,260
All Time High Change	-30.38%
All Time High Date	2025-01-08
All Time Low	421.4
All Time Low Change	108.19%
All Time Low Date	2024-06-04
ATR	36.06
Beta	-0.11
Beta1y	0.43
Beta2y	0.29
Ch YTD	21.82
High	900
High52	1,020.7
High52 Date	2025-06-13
High52ch	-14.06%
Low	830
Low52	622
Low52 Date	2026-03-02
Low52ch	41.03%
Ma50ch	22.81%
Price vs 200-day SMA	13.59%
RSI	78.35
RSI Monthly	54.39
RSI Weekly	66.82
Sharpe ratio	0.05x
Sortino ratio	0.27
Total Return	0.48%
Tr YTD	22.18
Tr1m	28.01%
Tr1w	3.88%
Tr3m	23.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.1B
Operating Income Growth	26.71
Operating Income Growth Q	43.87
Operating Income Growth3 Y	25.13
Operating margin	12.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,915,094%
Net Borrowing	-51,330,000
Shares Insiders	72.19%
Shares Institutions	18.12%
Shares Out	57,224,929
Shares Qo Q	0.14%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 491.8M
Average Volume	130,792.4x
Bv Per Share	190.5
CAPEX	INR -673.4M
Ch1m	28.01
Ch1w	3.88
Ch1y	0.16
Ch3m	23.96
Ch6m	14.29
Change	1.57%
Change From Open	3.11
Close	863.7
Days Gap	-1.49
Depreciation Amortization	451,790,000
Dollar Volume	136,694,953.2
Earnings Date	2026-05-07
EBIT	INR 2.1B
EBITDA	INR 2.5B
EPS	INR 24.63
F Score	6
FCF	INR 491.8M
FCF EV Yield	0.93x
FCF Per Share	INR 8.59
Financing CF	-217,150,000
Fiscal Year End	March
Founded	2,005
Goodwill	166,940,000
Graham Number	324.8925
Graham Upside	-62.96
Income Tax	INR 473.5M
Investing CF	-1,071,200,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	INR 616
Lynch Upside	-29.81
Ma150	731.4
Ma150ch	19.93%
Ma20	756.3
Ma20ch	15.99%
Net CF	-123,200,000
Next Earnings Date	2026-05-21
Open	850.8
P FCF Ratio	101.9
P OCF Ratio	43.01
Payment Date	2026-02-22
Position In Range	67.43
Ppne	8,388,370,000
Price Date	2026-05-08
Price EBITDA	INR 20.02
Ptbv Ratio	4.67
Relative Volume	1.23x
Revenue	16,374,380,000x
Tax By Revenue	2.89x
Tax Rate	25.15%
Tr6m	14.63%
Volume	155,831

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/INNOVACAP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$4.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-01-30

Performance

NSE/INNOVACAP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/INNOVACAP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.1%

Share of float held by funds and institutions

Insider ownership

+72.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/INNOVACAP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.3

Above 70: short-term overbought

Price vs 200-day MA

+13.6%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/INNOVACAP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/INNOVACAP stock rating?

nse/INNOVACAP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/INNOVACAP analysis?

The full report lives at /stocks/nse/INNOVACAP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/INNOVACAP?

The latest report frames nse/INNOVACAP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/INNOVACAP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.